AEZS
Price:
$5.72
Market Cap:
$17.51M
Aeterna Zentaris Inc., a specialty biopharmaceutical company, engages in developing and commercializing therapeutics and diagnostic tests. Its lead product is macimorelin, an orally available peptidomimetic ghrelin receptor (GHSR-1a) agonist that stimulates the secretion of growth hormone by binding to the GHSR-1a for the diagnosis of adult growth hormone deficiency and childhood-onset growth hormone deficiency, as well as oncology indications. The company markets macimorelin under the Macrilen brand name. Aeterna Zentaris Inc. has a license agreement with University Wuerzburg to research, develop, manufacture, and sell a potential COVID-19 vaccine; development, manufacture, and commercializ...[Read more]
Industry
Biotechnology
IPO Date
2000-05-10
Stock Exchange
NASDAQ
Ticker
AEZS
According to Aeterna Zentaris Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -2.48. This represents a change of 3.71% compared to the average of -2.39 of the last 4 quarters.
The mean historical PE Ratio of Aeterna Zentaris Inc. over the last ten years is -2.53. The current -2.48 PE Ratio has changed 9.71% with respect to the historical average. Over the past ten years (40 quarters), AEZS's PE Ratio was at its highest in in the June 2019 quarter at 239.65. The PE Ratio was at its lowest in in the March 2021 quarter at -75.30.
Average
-2.53
Median
-7.21
Minimum
-19.52
Maximum
46.18
Discovering the peaks and valleys of Aeterna Zentaris Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 504.54%
Maximum Annual PE Ratio = 46.18
Minimum Annual Increase = -646.93%
Minimum Annual PE Ratio = -19.52
Year | PE Ratio | Change |
---|---|---|
2023 | -2.14 | 30.72% |
2022 | -1.64 | -91.60% |
2021 | -19.52 | 42.86% |
2020 | -13.66 | 29.63% |
2019 | -10.54 | -122.82% |
2018 | 46.18 | -646.93% |
2017 | -8.44 | 41.41% |
2016 | -5.97 | 504.54% |
2015 | -0.99 | -88.45% |
2014 | -8.55 | -135.82% |
The current PE Ratio of Aeterna Zentaris Inc. (AEZS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.77
5-year avg
-9.50
10-year avg
-2.53
Aeterna Zentaris Inc.’s PE Ratio is less than Pulmatrix, Inc. (-0.67), less than Onconova Therapeutics, Inc. (-1.15), less than Catalyst Biosciences, Inc. (-0.44), less than Bio-Path Holdings, Inc. (-0.14), less than Moleculin Biotech, Inc. (-0.24), less than Adial Pharmaceuticals, Inc. (-0.34), less than Diffusion Pharmaceuticals Inc. (-0.00), less than Tonix Pharmaceuticals Holding Corp. (-0.00), less than Jaguar Health, Inc. (0), less than Acasti Pharma Inc. (-0.07), less than iBio, Inc. (-2.21), less than TransCode Therapeutics, Inc. (-0.29), less than Aditxt, Inc. (-0.10), less than Reviva Pharmaceuticals Holdings, Inc. (-0.02), less than Avenue Therapeutics, Inc. (-1.10), less than null (-0.31),
Company | PE Ratio | Market cap |
---|---|---|
-0.67 | $7.30M | |
-1.15 | $20.90M | |
-0.44 | $19.42M | |
-0.14 | $2.51M | |
-0.24 | $6.83M | |
-0.34 | $6.40M | |
-0.00 | $8.98M | |
-0.00 | $3.14M | |
0 | $10.26M | |
-0.07 | $24.44M | |
-2.21 | $15.35M | |
-0.29 | $4.56M | |
-0.10 | $1.68M | |
-0.02 | $44.68M | |
-1.10 | $4.05M | |
-0.31 | $0 |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Aeterna Zentaris Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Aeterna Zentaris Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Aeterna Zentaris Inc.'s PE Ratio?
How is the PE Ratio calculated for Aeterna Zentaris Inc. (AEZS)?
What is the highest PE Ratio for Aeterna Zentaris Inc. (AEZS)?
What is the 3-year average PE Ratio for Aeterna Zentaris Inc. (AEZS)?
What is the 5-year average PE Ratio for Aeterna Zentaris Inc. (AEZS)?
How does the current PE Ratio for Aeterna Zentaris Inc. (AEZS) compare to its historical average?